Simultaneous engagement of BDCA-2 and CD32a with complete BDCA-2 mAb, in contrast to ligation with F(ab′)2, synergizes inhibition of TLR9 signaling triggered by FcR-dependent SLE IC. Here, FCGR2A is linked to systemic lupus erythematosus.